In vivo disposition of doxorubicin is affected by mouse Oatp1a/1b and human OATP1A/1B transporters

No abstract is available for this paper.

• Publication year

  2014

• Venue

  International Journal of Cancer

• Publication date

  2014-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.28797PMID 24554572
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Murine Oatp1a/1b Uptake Transporters Control Rosuvastatin Systemic Exposure Without Affecting Its Apparent Liver Exposure

  2013cited by this paper
• Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver.

  2012cited by this paper
• The expression and function of organic anion transporting polypeptides in normal tissues and in cancer.

  2012cited by this paper
• Influence of Polymorphic OATP1B-Type Carriers on the Disposition of Docetaxel

  2012cited by this paper
• Clarithromycin Is Absorbed by an Intestinal Uptake Mechanism That Is Sensitive to Major Inhibition by Rifampicin: Results of a Short-Term Drug Interaction Study in Foals

  2012cited by this paper
• Enhanced expression of organic anion transporting polypeptides (OATPs) in androgen receptor-positive prostate cancer cells: possible role of OATP1A2 in adaptive cell growth under androgen-depleted conditions.

  2012cited by this paper
• Pharmacokinetic Impact of SLCO1A2 Polymorphisms on Imatinib Disposition in Patients With Chronic Myeloid Leukemia

  2011cited by this paper
• Expression of organic anion-transporting polypeptides 1B1 and 1B3 in ovarian cancer cells: relevance for paclitaxel transport.

  2011cited by this paper
• Frequencies of single-nucleotide polymorphisms of SLCO1A2, SLCO1B3 and SLCO2B1 genes in a Finnish population.

  2011cited by this paper
• High Impact of Oatp1a/1b Transporters on In Vivo Disposition of the Hydrophobic Anticancer Drug Paclitaxel

  2010cited by this paper
• Organic anion transporting polypeptide 1a/1b-knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs.

  2010cited by this paper
• Methotrexate Pharmacokinetics in Transgenic Mice with Liver-Specific Expression of Human Organic Anion-Transporting Polypeptide 1B1 (SLCO1B1)

  2009cited by this paper
• Tissue Distribution, Ontogeny, and Hormonal Regulation of Xenobiotic Transporters in Mouse Kidneys

  2009cited by this paper
• Impact of OATP transporters on pharmacokinetics

  2009cited by this paper
• Life-threatening toxicities in a patient with UGT1A1*6/*28 and SLCO1B1*15/*15 genotypes after irinotecan-based chemotherapy

  2009cited by this paper
• Different expression patterns of organic anion transporting polypeptides in osteosarcomas, bone metastases and aneurysmal bone cysts.

  2009cited by this paper
• Physiologically Based Pharmacokinetic Modeling to Predict Transporter-Mediated Clearance and Distribution of Pravastatin in Humans

  2009cited by this paper
• Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects.

  2009cited by this paper
• Impact of genetic polymorphisms of transporters on the pharmacokinetic, pharmacodynamic and toxicological properties of anionic drugs.

  2008cited by this paper
• Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family

  2008cited by this paper
• Global analysis of genetic variation in SLCO1B1.

  2008cited by this paper
• Interplay between the nuclear receptor pregnane X receptor and the uptake transporter organic anion transporter polypeptide 1A2 selectively enhances estrogen effects in breast cancer.

  2008cited by this paper
• Intestinal Drug Transporter Expression and the Impact of Grapefruit Juice in Humans

  2007cited by this paper
• Pharmacogenomics of human OATP transporters

  2006cited by this paper
• Carcinogen and Anticancer Drug Transport by Mrp2 in Vivo: Studies Using Mrp2 (Abcc2) Knockout Mice

  2006cited by this paper
• Expression of transporters potentially involved in the targeting of cytostatic bile acid derivatives to colon cancer and polyps.

  2006cited by this paper
• Past, present--and future?

  2005cited by this paper
• Polymorphisms in Human Organic Anion-transporting Polypeptide 1A2 (OATP1A2)

  2005cited by this paper
• TISSUE DISTRIBUTION AND ONTOGENY OF MOUSE ORGANIC ANION TRANSPORTING POLYPEPTIDES (OATPS)

  2005cited by this paper
• Characterization of the organic cation transporter SLC22A16: a doxorubicin importer.

  2005cited by this paper
• Anthracycline analogs The past, present, and future

  2004cited by this paper
• Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the Hepatic Uptake of Pitavastatin in Humans

  2004cited by this paper
• Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties

  2004cited by this paper
• Identification of OCT6 as a novel organic cation transporter preferentially expressed in hematopoietic cells and leukemias.

  2002cited by this paper
• LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers.

  2001cited by this paper
• Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family.

  2000cited by this paper
• A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane.

  2000cited by this paper
• Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier.

  2000cited by this paper
• The role of mdr1a P-glycoprotein in the biliary and intestinal secretion of doxorubicin and vinblastine in mice.

  2000cited by this paper
• Increased accumulation of doxorubicin and doxorubicinol in cardiac tissue of mice lacking mdr1a P-glycoprotein

  1999cited by this paper
• The mouse Bcrp1/Mxr/Abcp gene: amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin.

  1999cited by this paper
• A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin.

  1999cited by this paper
• Determination of doxorubicin and metabolites in murine specimens by high-performance liquid chromatography.

  1998cited by this paper

• Role of solute carrier transporters in the biodistribution and toxicity of chemotherapeutic drugs.

  2026cites this paper
• Preparation and Characterization of a Glutathione-Responsive Doxorubicin Prodrug Modified by 2-Nitrobenzenesulfonamide Group—Its Selective Cytotoxicity Toward Cells with Enhanced Glutathione Production

  2025influential citation
• Activation of pregnane X receptor-organic anion transporting polypeptide 1a/b /P-glycoprotein/multidrug resistance protein 2 axis mediates the accelerated blood and liver clearance of PEGylated liposomes.

  2025cites this paper
• Ribosomal RNA Degradation (RNA Disruption) in Tumour Cells: Mechanistic Insights and Potential Clinical Utility

  2025cites this paper
• Rivaroxaban Ameliorates Sunitinib-Induced Injury of Cardiomyocytes via Repressing MAPK Signaling Pathway

  2025cites this paper
• DNA-PKcs mediated transcriptional regulation of TOP2β drives chemoresistance in acute myeloid leukemia.

  2024cites this paper
• Exploring the effects of calycosin on anthracycline-induced cardiotoxicity: a network pharmacology, molecular docking, and experimental study

  2024cites this paper
• Metformin inhibits OCTN1- and OCTN2-mediated hepatic accumulation of doxorubicin and alleviates its hepatotoxicity in mice.

  2024cites this paper
• Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming.

  2023cites this paper
• Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia

  2022cites this paper
• Why Do Dietary Flavonoids Have a Promising Effect as Enhancers of Anthracyclines? Hydroxyl Substituents, Bioavailability and Biological Activity

  2022cites this paper
• The role of OATP1A1 in cholestasis and drug-induced toxicity: a systematic review

  2022cites this paper
• Clinical Relevance of Hepatic and Renal P‐gp/BCRP Inhibition of Drugs: An International Transporter Consortium Perspective

  2022cites this paper
• Transporters and Toxicity: Insights From the International Transporter Consortium Workshop 4

  2022cites this paper
• The effects of pazopanib on doxorubicin pharmacokinetics in children and adults with non-rhabdomyosarcoma soft tissue sarcoma: a report from Children’s Oncology Group and NRG Oncology study ARST1321

  2022cites this paper
• Genome-wide CRISPR/Cas9 screening in human iPS derived cardiomyocytes uncovers novel mediators of doxorubicin cardiotoxicity

  2021cites this paper
• Expression and Functional Contribution of Different Organic Cation Transporters to the Cellular Uptake of Doxorubicin into Human Breast Cancer and Cardiac Tissue

  2021cites this paper
• Contribution of membrane transporters to chemotherapy‐induced cardiotoxicity

  2021cites this paper
• Next generation risk assessment (NGRA): Bridging in vitro points-of-departure to human safety assessment using physiologically-based kinetic (PBK) modelling - A case study of doxorubicin with dose metrics considerations.

  2021cites this paper
• Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia

  2020cites this paper
• OATP1A/1B, CYP3A, ABCB1, and ABCG2 limit oral availability of the NTRK inhibitor larotrectinib, while ABCB1 and ABCG2 also restrict its brain accumulation

  2020cites this paper
• Novel insights into the organic solute transporter alpha/beta, OSTα/β: From the bench to the bedside.

  2020cites this paper
• Elucidation of OATP1B1 and 1B3 transporter function using transgenic rodent models and commonly known single nucleotide polymorphisms.

  2020cites this paper
• Human organic anion transporting polypeptide (OATP) 1B3 and mouse OATP1A/1B affect liver accumulation of Ochratoxin A in mice.

  2020cites this paper
• Gender Differences in the Effect of Calcitriol on the Body Disposition and Excretion of Doxorubicin in Mice

  2020cites this paper
• Solute Carrier Transportome in Chemotherapy-Induced Adverse Drug Reactions.

  2020cites this paper
• Organic anion transporting polypeptide 1A2 mediates fentanyl uptake in cultured cells.

  2019cites this paper
• Organic Anion Transporting Polypeptides: Emerging Roles in Cancer Pharmacology

  2019influential citation
• Neurovascular unit transport responses to ischemia and common coexisting conditions: smoking and diabetes.

  2019cites this paper
• Dioscorea bulbifera L. delays the excretion of doxorubicin and aggravates doxorubicin-induced cardiotoxicity and nephrotoxicity by inhibiting the expression of P-glycoprotein in mice liver and kidney

  2019cites this paper
• Brain Delivery of a Potent Opioid Receptor Agonist, Biphalin during Ischemic Stroke: Role of Organic Anion Transporting Polypeptide (OATP)

  2019cites this paper
• The Emerging Role of the SLCO1B3 Protein in Cancer Resistance

  2019cites this paper
• Drug transporters and anthracycline-induced cardiotoxicity.

  2018cites this paper
• A physiologically based pharmacokinetic (PBPK) parent-metabolite model of the chemotherapeutic zoptarelin doxorubicin—integration of in vitro results, Phase I and Phase II data and model application for drug–drug interaction potential analysis

  2018cites this paper
• The role of organic anion transporting polypeptides in drug absorption, distribution, excretion and drug-drug interactions

  2017cites this paper
• Contribution of Organic Anion-Transporting Polypeptides 1A/1B to Doxorubicin Uptake and Clearance

  2017influential citation
• A novel in vitro anticancer drug delivery strategy using platinum encapsulated gold nanoparticles.

  2017cites this paper
• Biopharmaceutical investigations of doxorubicin formulations used in liver cancer treatment : Studies in healthy pigs and liver cancer patients, combined with pharmacokinetic and biopharmaceutical modelling

  2017cites this paper
• A Model-Based Approach To Assessing the Importance of Intracellular Binding Sites in Doxorubicin Disposition.

  2017cites this paper
• Renal Drug Transporters and Drug Interactions

  2017cites this paper
• Intestinal Drug Interactions Mediated by OATPs: A Systematic Review of Preclinical and Clinical Findings.

  2017cites this paper
• The value of paradoxical uptake of hepatocellular carcinoma on the hepatobiliary phase of gadoxetic acid-enhanced liver magnetic resonance imaging for the prediction of lipiodol uptake after transcatheter arterial chemoembolization.

  2017cites this paper
• Inherited variation in OATP1B1 is associated with treatment outcome in acute myeloid leukemia

  2016cites this paper
• The impact of Organic Anion-Transporting Polypeptides (OATPs) on disposition and toxicity of antitumor drugs: Insights from knockout and humanized mice.

  2016cites this paper
• Absorció i metabolisme intestinal de l’àcid maslínic, un component bioactiu de l’Olea europaea L. Efecte quimiopreventiu sobre lesions preneoplàsiques en còlon de rata

  2015cites this paper
• Preclinical Mouse Models To Study Human OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions in Vivo.

  2015cites this paper
• Regulation of the expression of renal drug transporters in KEAP1-knockdown human tubular cells.

  2015cites this paper
• MOLECULAR AND FUNCTIONAL INVESTIGATION OF CANCER-TYPE AND LIVER-TYPE VARIANTS OF ORGANIC ANION TRANSPORTING POLYPEPTIDE 1B3

  2015cites this paper
• Biopharmaceutical Evaluation of Intra-arterial Drug-Delivery Systems for Liver Cancer : Investigations in healthy pigs and liver cancer patients

  2015cites this paper
• Role of Organic Anion-Transporting Polypeptides (OATPs) in Cancer Therapy

  2015cites this paper
• The Altered Renal and Hepatic Expression of Solute Carrier Transporters (SLCs) in Type 1 Diabetic Mice

  2015cites this paper
• Cetuximab directly inhibits P-glycoprotein function in vitro independently of EGFR binding.

  2015cites this paper